Skip to content

10-QAccepted Feb 6, 7:24 AM ET

Immunovant, Inc. 10-Q

IMVTImmunovant, Inc.

Accepted (ET)

7:24 AM

Feb 6, 2026

Filed

Feb 6, 2026

Documents

60

Size

5.6 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.